shareholdersunite.com

Opportunities in smallcaps

shareholdersunite.com header image 2

BioLife’s Huge Valuation Gap With CryoPort Is Difficult To Explain

July 13th, 2019 · No Comments

  • Both companies operate in the same market and are of similar size and produce comparable growth rates, yet CryoPort sells at 2.5x the valuation of BioLife.
  • Operationally BioLife is much superior in terms of profits, cash flow, margins compared with CryoPort’s history of losses, cash burn, lower margins, debt and dilution.
  • CryoPort has a more established distribution business but don’t count the distribution business of BioLive out just yet, as they had a notable customer win recently.

Source: BioLife’s Huge Valuation Gap With CryoPort Is Difficult To Explain – BioLife Solutions, Inc. (NASDAQ:BLFS) | Seeking Alpha

Tags: BLFS